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Expression and Characterization of Antimicrobial Peptides Retrocyclin-101 and
Protegrin-1 in Chloroplasts to Control Viral and Bacterial Infections
Abstract
Retrocyclin-101 (RC101) and Protegrin-1 (PG1) are two important antimicrobial peptides that can be used
as therapeutic agents against bacterial and/or viral infections, especially those caused by the HIV-1 or
sexually transmitted bacteria. Because of their antimicrobial activity and complex secondary structures,
they have not yet been produced in microbial systems and their chemical synthesis is prohibitively
expensive. Therefore, we created chloroplast transformation vectors with the RC101 or PG1 coding
sequence, fused with GFP to confer stability, furin or Factor Xa cleavage site to liberate the mature
peptide from their fusion proteins and a His-tag to aid in their purification. Stable integration of RC101
into the tobacco chloroplast genome and homoplasmy were confirmed by Southern blots. RC101 and
PG1 accumulated up to 32%–38% and 17%~26% of the total soluble protein. Both RC101 and PG1 were
cleaved from GFP by corresponding proteases in vitro, and Factor Xa–like protease activity was observed
within chloroplasts. Confocal microscopy studies showed location of GFP fluorescence within
chloroplasts. Organic extraction resulted in 10.6-fold higher yield of RC101 than purification by affinity
chromatography using His-tag. In planta bioassays with Erwinia carotovora confirmed the antibacterial
activity of RC101 and PG1 expressed in chloroplasts. RC101 transplastomic plants were resistant to
tobacco mosaic virus infections, confirming antiviral activity. Because RC101 and PG1 have not yet been
produced in other cell culture or microbial systems, chloroplasts can be used as bioreactors for producing
these proteins. Adequate yield of purified antimicrobial peptides from transplastomic plants should
facilitate further preclinical studies.
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Expression and characterization of antimicrobial peptides
Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral
and bacterial infections
Seung-Bum Lee†, Baichuan Li†, Shuangxia Jin, and Henry Daniell*
Department of Molecular Biology and Microbiology, College of Medicine, University of Central
Florida, Orlando, FL, USA

Summary
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Retrocyclin-101 (RC101) and Protegrin-1 (PG1) are two important antimicrobial peptides that can
be used as therapeutic agents against bacterial and/or viral infections, especially those caused by
the HIV-1 or sexually transmitted bacteria. Because of their antimicrobial activity and complex
secondary structures, they have not yet been produced in microbial systems and their chemical
synthesis is prohibitively expensive. Therefore, we created chloroplast transformation vectors with
the RC101 or PG1 coding sequence, fused with GFP to confer stability, furin or Factor Xa
cleavage site to liberate the mature peptide from their fusion proteins and a His-tag to aid in their
purification. Stable integration of RC101 into the tobacco chloroplast genome and homoplasmy
were confirmed by Southern blots. RC101 and PG1 accumulated up to 32%–38% and 17%~26%
of the total soluble protein. Both RC101 and PG1 were cleaved from GFP by corresponding
proteases in vitro, and Factor Xa–like protease activity was observed within chloroplasts.
Confocal microscopy studies showed location of GFP fluorescence within chloroplasts. Organic
extraction resulted in 10.6-fold higher yield of RC101 than purification by affinity
chromatography using His-tag. In planta bioassays with Erwinia carotovora confirmed the
antibacterial activity of RC101 and PG1 expressed in chloroplasts. RC101 transplastomic plants
were resistant to tobacco mosaic virus infections, confirming antiviral activity. Because RC101
and PG1 have not yet been produced in other cell culture or microbial systems, chloroplasts can be
used as bioreactors for producing these proteins. Adequate yield of purified antimicrobial peptides
from transplastomic plants should facilitate further preclinical studies.
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Introduction
Antimicrobial peptides are evolutionarily conserved components of the innate immune
response and are found in different organisms, including bacteria, vertebrates, invertebrates
and plants (Boman, 1995; Nicolas and Mor, 1995; Broekaert et al., 1997; Hancock and
Chapple, 1999). Antimicrobial peptides are also called peptide antibiotics. When compared
with conventional antibiotics, development of resistance is less likely with antimicrobial
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peptides. Many bacteria species remain sensitive to antimicrobial peptides after a long time
of evolution (Yeaman and Yount, 2003; Nizet, 2006). Adaptive immune systems can
remember the pathogen and elicit a much faster and stronger immune response against that
pathogen at subsequent encounters (Boman, 1995). Without such specificity and memory,
antimicrobial peptides evolved a different mechanism against pathogen infections. Most
antimicrobial peptides are efficient against a broad spectrum of pathogens rather than
specific against one pathogen, which makes them especially suitable for use against local
and systematic infections (Bals, 2000; Schaller-Bals et al., 2002). Other than the
antimicrobial activities, some antimicrobial peptides are shown to have immunomodulatory
activities. Some studies show that antimicrobial peptides such as defensins are likely to play
a role in recruiting effector T cells to inflammatory sites, thereby contributing to the effector
phase of adaptive immunity (Yang et al., 2001). These intriguing characteristics of
antimicrobial peptides facilitate development of novel antibiotics. However, the high cost of
production of antimicrobial peptides and lack of suitable expression systems could be
potential barriers for their development and clinical studies.

NIH-PA Author Manuscript
NIH-PA Author Manuscript

The chloroplast, as a bioreactor, is able to express foreign proteins at high levels because of
their high copy numbers. When a transgene is integrated into the inverted repeat region of
the chloroplast genome, up to 20 000 copies of the transgene per cell could be expressed.
Several therapeutic proteins have been expressed in chloroplasts, including human blood
proteins somatotropin (Staub et al., 2000), insulin-like growth factor (Daniell et al., 2009),
proinsulin (Ruhlman et al., 2007), IFN-α2b (Arlen et al., 2007), serum albumin (FernandezSan et al., 2003), IFN-γ (Leelavathi and Reddy, 2003), cardiotrophin-1 (Farran et al., 2008),
alpha1-anti-trypsin (Nadai et al., 2009) and glutamic acid decarboxylase (Wang et al., 2008).
In addition, several vaccine antigens have been expressed in chloroplasts against several
bacterial pathogens including cholera toxin B subunit (Daniell et al., 2001), tetanus toxin
(Tregoning et al., 2003), anthrax protective antigen (Watson et al., 2004; Koya et al., 2005),
plague F1-V fusion antigen (Arlen et al., 2008), and outer surface lipoprotein A (OspA) for
Lyme disease (Glenz et al., 2006), and their functionality has been evaluated in cell culture
systems or animal models after pathogen or toxin challenges. Antigens produced against
protozoan pathogens were immunogenic against amoeba (Chebolu and Daniell, 2007) or
effective against the malarial parasite (Davoodi-Semiromi et al., 2009). Although several
viral antigens have been expressed in chloroplasts, neutralizing antibodies were shown only
against human papillomavirus (Fernandez-San et al., 2008) and canine parvovirus 2L21
peptide (Molina et al., 2004). Other proteins expressed in chloroplasts include bovine
mammary-associated serum amyloid (Manuell et al., 2007), aprotinin (Tissot et al., 2008)
and monoclonal large single-chain (lsc) antibody against glycoprotein D of the herpes
simplex virus (Mayfield et al., 2003). The expression levels of these proteins are mostly
2%~20% of total soluble protein (TSP) but could be even higher than RuBisCo (Oey et al.,
2009; Ruhlman et al., 2010). Other advantages of chloroplast transformation include multigene engineering, transgene containment, lack of position effect, gene silencing and
maternal inheritance (Daniell et al., 2005; 2009).
Retrocyclin is a cyclic octadecapeptide, which is artificially synthesized based on a human
pseudogene that is homologous to rhesus monkey circular minidefensins. Retrocyclin
contains six cysteines and has large β-sheet structure that is stabilized by three
intramolecular disulphide bonds. Structure–function studies indicate that the cyclic
backbone, intramolecular tri-disulphide ladder, and arginine residues of retrocyclin
contributed substantially to its protective effects (Trabi et al., 2001; Jenssen et al., 2006).
Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and
viruses, especially against HIV retrovirus or sexually transmitted bacteria. Previous studies
have shown that Retrocyclin-101 (RC101) and other retrocyclins can protect human CD4+
cells from infection by T- and M-tropic strains of HIV-1 in vitro (Cole et al., 2002) and
Plant Biotechnol J. Author manuscript; available in PMC 2012 October 11.
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prevent HIV-1 infection in an organ-like construct of human cervicovaginal tissue (Cole et
al., 2007). The ability of RC101 to prevent HIV-1 infection and retain full activity in the
presence of vaginal fluid makes it a good candidate for topical microbicide to prevent sexual
transmission of HIV-1.
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Protegrin-1 (PG1) belongs to the protegrin family, which is discovered in porcine leucocytes
(Kokryakov et al., 1993). PG1 is a cysteine-rich, 18-residue β-sheet peptide. It has a high
content of arginine, an amidated C-terminus, and four conserved cysteines at positions 6, 8,
13 and 15, which would form two disulphide bonds. The antimicrobial activity of PG1 is
strongly related to the stability of β-hairpin conformation, and the β-hairpin conformation of
PG1 is stabilized by the two disulphide bonds. Removal of both disulphide bonds would
result in substantial reduction of PG1's activity (Harwig et al., 1996; Chen et al., 2000).
Therefore, the disulphide bridges are very important to the activity of PG1. It was shown
that PG1 had potent antimicrobial activity against a broad spectrum of microorganisms,
including bacteria, fungi and yeasts (Kokryakov et al., 1993; Steinberg et al., 1997).
Chlamydia trachomatis and Neisseria gonorrhoeae are two kinds of pathogenic bacteria that
can cause sexually transmitted diseases (STDs) in humans. Two previous studies that
compare the efficiency of PG1 with human neutrophil defensins demonstrated that PG1 is
more potent than human neutrophil defensins in inactivating C. trachomatis and N.
gonorrhoeae (Qu et al., 1996; Yasin et al., 1996). Therefore, a combination of RC101 and
PG1 should be able to inactivate most bacterial and viral pathogens, and they will be
especially effective against bacteria and viruses that cause STDs.

NIH-PA Author Manuscript

In a previous study, our laboratory expressed the antimicrobial peptide MSI-99, an analogue
of magainin 2, via the chloroplast genome to obtain high levels of protection against
bacterial and fungal pathogens (DeGray et al., 2001). Recently, a proteinaceous antibiotic,
PlyGBS lysin, was also expressed in the chloroplast, and it was shown that the protein
synthesis capacity of the chloroplast was exhausted by the massive production of the foreign
protein (Oey et al., 2009). However, antimicrobial peptides containing multiple
intramolecular disulphide bonds have not yet been expressed in chloroplasts. In this study,
we investigated expression of functional disulphide-bonded antimicrobial peptides in
chloroplasts. The rationale is that chloroplasts have already been shown in previous studies
to be fully functional in expressing biologically active, disulphide-bonded therapeutic
proteins, such as human somatotropin (Staub et al., 2000), cholera toxin B (Daniell et al.,
2001), human interferon-α2b (Arlen et al., 2007) and alkaline phosphatases (Bally et al.,
2008). Because of the high cost associated with chemical synthesis and inability of cell
culture or microbial systems to produce these proteins, expression of RC101 or PG1
antimicrobial peptides in chloroplasts would be an ideal solution for their large-scale
economic production.

Results
Construction of chloroplast transformation vectors
Two chloroplast transformation vectors were designed for expressing RC101 and PG1 in
chloroplasts. They were constructed using the basic pLD vector, which was developed in our
laboratory for chloroplast transformation (Daniell et al., 1998; Verma et al., 2008). Both
PG1 and RC101 were fused with GFP gene because of their small sizes (18 amino acids).
Besides, GFP was used as a reporter and to aid in quantification of the fusion proteins. A 6histidine tag was also engineered upstream of RC101/PG1 to facilitate purification of these
fusion proteins. A furin protease cleavage site was engineered between PG1 and GFP, while
a Factor Xa protease cleavage site was engineered between RC101 and the 6-histidine tag to
facilitate release of PG1/RC101 from these fusion proteins. The promoter and 5′untranslated region (UTR) of the tobacco psbA gene was placed upstream of the His6-GFPPlant Biotechnol J. Author manuscript; available in PMC 2012 October 11.
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Furin-PG1/GFP-His6-Xa-RC101 transgene cassette to enhance expression of these fusion
proteins. The aadA gene, which conferred resistance to spectinomycin, was driven by the
constitutive Prrn promoter. The flanking sequences of trnI and trnA facilitated
recombination with the native chloroplast genome (Figure 1b,c). The transgene fragment
sequences and the disulphide bonds of RC101 and PG1 are shown in Figure 1d,e.
Confirmation of transgene cassette integration and homoplasmy
Several primary shoots appeared from the RC101- and PG1-bombarded tobacco leaves, and
they were developed through three rounds of selection. To confirm integration of transgene
cassettes into the chloroplast genome, the putative transformed shoots were screened by
PCR. Two pairs of primers were used for screening. The 3P and 3M primers were used to
check site-specific integration of the selectable marker gene (aadA) into the chloroplast
genome. The 5P and 2M primers were used to check integration of the transgene expression
cassette (Figure 1b,c). DNA template from the RC101-GFP and PG1-GFP transplastomic
shoots yielded PCR products with both primers (Figure 2a,b). The 3P-3M PCR products for
both the RC101 and PG1 transformants were 1.65 kbp, and 5P-2M PCR products were 2.6
kbp. Because the sizes of the RC101 and PG1 transgene expression cassette (including GFP)
were similar, PCR product sizes were also similar. These PCR products could be generated
only from transformed chloroplasts and not nuclear transformants or spontaneous mutants.

NIH-PA Author Manuscript

Because there are thousands of copies of chloroplast genomes in each plant cell, some of
them may not be transformed. Therefore, Southern blot was performed to investigate
whether RC101 and PG1 transplastomic plants achieved homoplasmy. The probe used was
made by digesting the flanking sequences trnI and trnA with BamHI and BglII (Figure 1a).
Flanking sequence probe identified a single 4.0-kbp fragment in the untransformed tobacco,
as expected. In the RC101 and PG1 transplastomic lines, only one 6.4-kbp fragment was
observed (Figure 2c). Absence of the 4.0-kbp fragment confirmed that all the chloroplast
genomes were transformed (to the detection limit of Southern blots), and therefore, they are
considered to be homoplasmic.
Evaluation of RC101 or PG1 expression in transgenic chloroplasts

NIH-PA Author Manuscript

To evaluate expression of foreign genes in chloroplasts of RC101-GFP and PG1-GFP
transplastomic lines, immunoblots using GFP antibodies were performed. Based on the TSP
concentration, same amount of protein extracts from RC101 and PG1 transplastomic lines
(before and after pro-tease digestion) were resolved on 12% SDS-PAGE gels. The size of
RC101 is 1.9 kDa, while the size of PG1 is 2.1 kDa. Therefore, the sizes of RC101-GFP and
PG1-GFP are both ~29 kDa. After cleavage of RC101 and PG1 from GFP, we should
observe only the 27 kDa GFP polypeptide. The immunoblot result is shown in Figure 3a.
Clearly, the fusion proteins were cleaved after protease digestion.
An alternative approach to confirm the expression of RC101-GFP and PG1-GFP proteins is
to observe the green fluorescence emitted by GFP. After crude protein extracts were
resolved on the native polyacrylamide gel, the green fluorescence emitted by GFP fusion
proteins was observed under the UV light. The green peptides shown correspond to the GFP
fusion proteins. The strong green fluorescence observed indicated that GFP fusion proteins
were expressed at high levels (Figure 3b). The expression of RC101 and PG1 transplastomic
plants was quantified using the GFP fluorescence by densitometric analysis. The integrated
density values (IDVs) of GFP fluorescence were measured by spot densitometry. The linear
GFP standard curve was established using 150–600 ng of GFP standard protein (Figure 3c).
Based on this GFP standard curve, the expression levels of RC101 and PG1 transplastomic
plants were estimated to be approximately 35% and 25% of TSP (Figure 3d). To confirm the
expression levels of the transplastomic plants, ELISA was also performed to determine the

Plant Biotechnol J. Author manuscript; available in PMC 2012 October 11.

Lee et al.

Page 5

NIH-PA Author Manuscript

quantities of RC101-GFP and PG1-GFP fusion proteins in transplastomic tobacco plants.
Because the antimicrobial peptides RC101 and PG1 were fused with GFP proteins, ELISA
was performed using the GFP antibodies to quantify the RC101-GFP and PG1-GFP fusion
proteins. RC101-GFP accumulated to 32%~38% of TSP, and PG1-GFP accumulated to
17%~26% of TSP. This variation of expression levels could be attributable to leaf samples
harvested from plants under different periods of illumination.
Dot blot analysis was also performed to evaluate the expression of RC101 in transgenic
chloroplasts. Factor Xa-cleaved samples and Factor Xa-uncleaved samples from RC101
transplastomic plants were tested by dot blots. It is shown that both uncut and cut samples of
RC101-GFP appeared positive (Figure 4a). As shown in previous experiments (Figure 3a),
RC101-GFP fusion proteins were already partially cleaved by Factor Xa within chloroplasts.
Because PG1 was not immunogenic, dot blot analysis could not be performed with PG1
transplastomic plants. Instead, PG1 protein expression was examined by silver staining. By
comparison of cut and uncut samples from PG1 transplastomic plants, it is clear that there is
a 2 kDa polypeptide present in the furin-digested sample but absent in the uncut sample and
untransformed tobacco protein extract (Figure 4b). The size of PG1 is 2.16 kDa, and
therefore, this polypeptide should correspond to the PG1 protein.
RC101 and PG1 were expressed and contained within chloroplasts
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To investigate whether the chloroplasts remained intact when RC101 or PG1 antimicrobial
peptides were highly expressed in chloroplasts, fresh leaves were examined under the
confocal microscope. Strong green fluorescence was emitted from the RC101 and PG1
transplastomic lines (Figure 5a,b). We observed that chloroplasts emitting green
fluorescence formed circles around each cell. There was no GFP fluorescence outside
chloroplasts. This observation confirmed that chloroplasts remained intact because GFPfused antimicrobial proteins were not released into the cytoplasm in any detectable quantity.
Purification of RC101-GFP and PG1-GFP fusion proteins

NIH-PA Author Manuscript

We then tried to purify the RC101-GFP and PG1-GFP fusion proteins. The engineered Histag and GFP protein facilitated purification of RC101-GFP and PG1-GFP fusion proteins.
We tried to purify the fusion proteins by affinity chromatography using His-tag or organic
extraction through GFP. Results of purification using both methods are shown in Figure 6.
Approximately 8 μg of purified PG1-GFP and 5 μg of purified RC101-GFP were obtained
from one gram of fresh tobacco leaf using the affinity chromatography method. In contrast,
purification of RC101-GFP using the organic extraction method resulted in a yield of 53 μg
of purified RC101-GFP per gram of fresh tobacco leaf. The organic extraction method
resulted in much higher yield than the affinity chromatography method. It is evident that
monomers, dimers and multimers of the RC101-GFP were recovered by organic extraction
method, resulting in 10.6-fold higher yield, whereas only the monomer was recovered using
the affinity chromatography. The highly enriched fraction was the RC101-GFP monomer,
~29 kDa in size. The upper bands should be dimers and multimers formed by RC101-GFP
proteins. This same pattern was observed in the native gel electrophoresis of RC101-GFP
transplastomic plant protein extracts (Figure 3b). PG1-GFP protein was purified only by
affinity chromatography, and we could observe a single band, which should be the monomer
form of PG1-GFP.
RC101 and PG1 retained their antimicrobial activity when expressed in chloroplasts
Retrocyclin-101, as a member of the θx-defensin family, possesses antibacterial activity as
well as antiviral activity (Tang et al., 1999). To investigate the functionality of RC101 and
PG1 expressed in the tobacco chloroplasts, we performed both antibacterial and antivirus
assays using plant pathogens because use of HIV and other human bacterial pathogens
Plant Biotechnol J. Author manuscript; available in PMC 2012 October 11.
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requires higher levels of containment than our current facilities. The antibacterial activity of
RC101 and PG-1 was studied by investigating enhanced resistance to Erwinia soft rot using
either the syringe or sand paper method. One day after inoculation with Erwinia, the first
signs of damage were observed on leaves of untransformed plants in the regions of
inoculation. On the third day, virtually all inoculated untransformed leaf surfaces underwent
necrosis, whereas in leaves of RC101 or PG1 transplastomic plants, no or minimally
damaged zones were observed depending on the number of bacteria inoculated. Inoculation
of potted plants with Erwinia carotovora using a syringe method resulted in areas of necrosis
surrounding the point of inoculation in untransformed control for all cell densities (Figure
7b,f), whereas transplastomic RC101 and PG-1 mature leaves showed no areas of necrosis
(Figure 7a,e). Even inoculation of 108 cells resulted in no or minimal necrosis in mature
transplastomic leaves. In contrast, untransformed plants inoculated with 102 cells displayed
obvious necrosis. Similar results were obtained with E. carotovora inoculated by the sand
paper method. Transplastomic mature leaves inoculated with E. carotovora showed no
necrosis (Figure 7c) or a mild discoloration at the site of inoculation of 108 cells (Figure 7g),
and untransformed plants inoculated with 102 cells or higher density displayed obvious
necrosis (Figure 7d,h).
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The bacterial count in inoculated plants was also estimated. Bacterial suspensions (1.0 × 105
cfu/mL) of E. carotovora were inoculated into transplastomic and untransformed leaves by a
syringe. Following inoculation, the density of E. carotovora in untransformed, RC101 and
PG-1 transplastomic leaves was less than 1 × 105 cfu/cm2 at 0 day postinoculation. Three
days after inoculation, the population of E. carotovora in untransformed tobacco leaves
reached 2.0 × 108 cfu/cm2 (Figure 8a,b). In comparison, the density of E. carotovora was
less than 1 × 104 cfu/cm2 in both RC101 (Figure 8a) and PG1 (Figure 8b) transplastomic
leaves 3 days after inoculation, a 10 000-fold reduction in bacterial burden. In addition, no
apparent symptoms of necrosis were observed in any of the RC101 or PG1 plants. These
results demonstrated that the RC101 and PG1 transplastomic plants are resistant to E.
carotovora. Therefore, RC101 and PG1 maintained their antibacterial activity when
expressed in chloroplasts.
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To determine the antiviral activity of PG1 and RC101 when expressed in tobacco
chloroplasts, transplastomic and untransformed control plants were tested for tobacco
mosaic virus (TMV) infection for 20 days. In susceptible untransformed control and PG1
plants, TMV multiplied and spread throughout the plants, causing typical mosaic, necrosis
and wrinkle symptoms within 20 days after inoculation (Figure 9a,b). However, the RC101
transplastomic plants did not show obvious symptoms of TMV infection, and the plants
grew well (Figure 9c). These results confirmed the antiviral activity of RC101 by conferring
resistance to TMV when expressed in chloroplasts.

Discussion
RC101 and PG1 are antimicrobial peptides that have potent antimicrobial activities against a
broad spectrum of microorganisms. Both RC101 and PG1 are disulphide-bonded proteins.
RC101 contains three and PG1 contains two intramolecular disulphide bonds that are
important for their antimicrobial activities (Harwig et al., 1996; Chen et al., 2000; Trabi et
al., 2001; Jenssen et al., 2006). Because RC101 and PG1 are microbicidal and contain
multiple disulphide bonds, they have not yet been produced in microbial or cell culture
systems. The goal of our study is to produce low-cost and functional RC101 and PG1
antimicrobial peptides in transgenic tobacco chloroplasts.
Our laboratory has previously expressed antimicrobial peptide MSI-99 in transgenic tobacco
chloroplasts without harmful effects to transplastomic plants. MSI-99 is an analogue of a
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naturally occurring peptide (magainin 2) found in the skin of the African frog (Jacob and
Zasloff, 1994). In another study, a proteinaceous antibiotic called PlyGBS lysine was
expressed in tobacco chloroplasts to high levels (>70% TSP, Oey et al., 2009). The PlyGBS
transplastomic plants showed delayed growth and a slightly pale-green phenotype when
compared to the untransformed plants. The authors suggested that it was attributable to the
exhaustion of protein synthesis capacity of transgenic chloroplasts by the massive overexpression of PlyGBS although expression of >70% TSP of CTB-proinsulin yielded healthy
transplastomic plants (Ruhlman et al., 2010). Previously expressed antimicrobial peptides
did not contain disulphide bonds, whereas the RC101 and PG1 antimicrobial peptides have
β-sheet structures and contain multiple intramolecular disulphide bonds. Therefore, efforts
to express RC101 and PG1 in transgenic chloroplasts should further expand the applications
of the chloroplast transformation system.
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To facilitate expression of small antimicrobial peptides RC101 and PG1 in tobacco
chloroplasts, each peptide was translationally fused with the GFP. This also facilitated
detection and quantification of RC101-GFP and PG1-GFP in chloroplasts. The expression of
GFP fusion proteins was visualized by examination under UV light or in immunoblots using
the anti-GFP antibody. ELISA was also performed using anti-GFP antibody to quantify the
expression of fusion proteins. Factor Xa protease cleavage site was inserted between RC101
and GFP and the furin cleavage site was inserted between PG1 and GFP, so that they could
be cleaved from their fusion proteins by appropriate proteases. It is interesting to note that
RC101-GFP protein was already partially cleaved within chloroplasts, suggesting the
presence of Factor Xa–like protease activity within chloroplasts.
The smaller green fluorescent peptides observed in RC101 and PG1 lanes in Figure 3b
should be the monomer form of RC101-GFP or PG1-GFP. The monomers ran faster than the
GFP standard, probably because GFP, when fused with RC101 or PG1, has higher
electrophoretic mobility in native gels. Different sizes correspond to the multimers formed
by the GFP fusion proteins. GFP protein did not form multimers. Therefore, the formation of
multimers by RC101-GFP or PG1-GFP fusion proteins is probably because of folded
antimicrobial peptides RC101 or PG1, which are disulphide-bonded proteins. Similar
folding pattern has also been observed before when proteins containing multiple disulphide
bonds were expressed in chloroplasts, including CTB-proinsulin (Ruhlman et al., 2007) and
interferon-α2b (Arlen et al., 2007).
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The toxicity of antimicrobial peptides is specific against microbial membranes and therefore
can be safely applied to mammals, including human beings. The composition of the
membranes is likely to be the determining factor for their selectivity. Biomembranes of
prokaryotic or eukaryotic cells differ significantly. Mammalian cytoplasmic membranes are
mainly composed of phosphatidylcholine, phosphatidylethanolamine, sphingomyelin and
cholesterol, which are all generally neutrally charged. In contrast, in many bacterial
pathogens, the membranes are composed predominantly of phosphatidylglycerol (PG),
cardiolipin and phosphatidylserine, which are highly electronegative (Yeaman and Yount,
2003). Most antimicrobial peptides, including RC101 and PG1, are positively charged under
physiological pH because they are rich in Arginine. Therefore, the net negative charge of the
biomembranes makes them the preferred target sites of antimicrobial peptides. The
chloroplast envelope and thylakoid membranes predominantly possess three glycolipids:
monogalactosyl diacylglycerol (MGDG), digalactosyl diacylglycerol (DGDG) and
sulfoquinovosyl diacylglycerol (SQDG), and a sole phospholipid: PG. SQDG and PG,
distinct from the noncharged MGDG and DGDG, are negatively charged. However, MGDG
makes up 50% of chloroplast membrane lipid and DGDG makes up 30%, suggesting that the
major components of chloroplast membranes are neutral. In this study, we examined fresh
leaves of RC101 and PG1 transplastomic plants under confocal microscope. Confocal
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images showed that GFP fusion proteins were contained within chloroplasts and were not
released into the cytoplasm. Cationic antimicrobial peptides including RC101 and PG1 kill
bacteria by disrupting their membranes. Although the chloroplast membrane structure
cannot be resolved from the confocal images shown in Figure 5, no GFP fluorescence was
detected outside the chloroplasts, suggesting that chloroplasts are not disrupted.
RC101-GFP and PG1-GFP accumulated up to 32%~38% and 17%~26% of TSP, and they
were purified by affinity chromatography or organic extraction method. The results showed
that organic extraction resulted in nearly 10-fold higher yield than the affinity
chromatography method (53 vs 5 μg/g fresh leaf). PG1 was only purified by affinity
chromatography, and the yield was 8 μg/g of fresh leaf. We did not observe dimers or
multimers in RC101-GFP or PG1-GFP samples purified by affinity chromatography, which
indicated that they were lost during the purification process. The His-tag was not accessible
in the dimer or multimer forms of RC101-GFP and PG1-GFP. Therefore, most of the fusion
proteins were not bound to the affinity column and lost during purification.
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Previous study reported that the minimum inhibitory concentrations of PG-1 against grampositive or gram-negative bacteria ranged from 0.12 to 2 μg/mL (Steinberg et al., 1997).
Retrocyclin (10–20 μg/mL) can inhibit proviral DNA formation and protect human CD4+
lymphocytes from in vitro infection by both T-tropic and M-tropic strains of HIV-1 (Cole et
al., 2002). RC101, as low as 2 μg, can prevent HIV-1 infection in an organ-like construct of
human cervicovaginal tissue (Cole et al., 2007). In another study, it was reported that
Retrocyclin-1, an analogue of RC101, can kill vegetative Bacillus anthracis cells with an
minimum effective concentration <1 μg/mL (Wang et al., 2006). As can be seen from these
published data, antimicrobial peptides are highly potent and their effective dosage is only
few microgram per millilitre. Although our purification yield is relatively low, tobacco can
be scaled up to yield up to 40 metric tons of biomass/acre/year. One acre of RC101
transplastomic tobacco plants could potentially yield up to 2 kg of purified RC101 by
organic extraction. Therefore, adequate quantities of RC101 or PG1 could be purified from
transplastomic plants for preclinical or clinical studies.
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RC101 and PG1 are shown to be functional when expressed in chloroplasts. Both RC101
and PG1 protected the transgenic tobacco plants from bacterial infection caused by E.
carotovora. In the antiviral assays, RC101 transgenic plants were resistant to TMV infection,
but PG1 transgenic plants showed the symptoms of mosaic, necrosis and wrinkle as
untransformed plants. Although PG1 has a broad-spectrum antimicrobial activity against
bacteria, virus and fungus, it is most effective against bacterial infections, especially
antibiotic-resistant bacteria (Kokryakov et al., 1993; Qu et al., 1996; Yasin et al., 1996;
Steinberg et al., 1997). In our study, PG1 is not effective in protecting plants from TMV
infection. RC101 is an analogue of retrocyclin, and it is especially effective in protecting
against viral infections. Several previous studies have shown that RC101 can be used to
prevent HIV-1 infection (Cole et al., 2002, 2007). Our study shows that RC101 is active
against the retrovirus TMV when expressed in chloroplasts. The antimicrobial activities of
RC101 and PG1 can protect plants from phytopathogen infections, which make them good
candidates to engineer disease-resistant plants. Because the use of HIV and other human
bacterial or viral pathogens requires higher levels of containment than our current facilities,
these studies were not performed. Future studies will include testing RC101 and PG1 in
suitable animal models against bacterial or viral pathogens.
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Experimental procedures
Construction of chloroplast transformation vectors
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The 6xHis-Factor Xa-RC101 sequence was synthesized by Klenow fragment, and it was
flanked by EcoRV and NotI restriction sites. The oligomers used were the following:
C2Fwd (5′GATATCCATCATCATCATCATCATATCGAAGGCCGCGGTATTTGTAGATGTATTT
GTGGTAAAGGTATTT-3′) and C2Rev (3′-CGGCGCCATAAACATCTACATAAAC
ACCATTTCCATAAACATCTACATAAACACCATCTATTCGCCGGCG-5′ or 5′GCGGCCGCTTATCTACCACAAATACATCTACAAATACCTTTACCACAAATACAT
CTACAAATACCGCGGC-3′). Soluble modified GFP (sm-GFP) protein was cloned into
the pGEM-T vector. The 6xHis-Factor Xa-RC101 sequence was cleaved by EcoRV and
NotI and subcloned into the pGEM-GFP vector. Then GFP-6xHis-Factor Xa-RC101 was
digested by NdeI (partial) and NotI and subcloned into the pLD vector (Daniell et al., 1998,
2001).
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The EcoRV-Furin-PG1-NotI sequence was synthesized by Klenow fragment. The oligomers
used were the following: EcoRV-Start Codon-Furin-PG1 (5′-GTC-GATATC-ATGGGCCAAAAACGAAGGGGAGGTCGCCTGTGCTATTGTAGGCGTAGGTTCTGCGTC
TGT) and NotI-stop codon-reverse PG1 (5′-GCA-GCGGCCGC-TCATCCTCGTCCGACACAGACGCAGAACCTACGCCTACAATAGCACAGGCGACCTCC
CCT-3′). A 6xHis tag was introduced by PCR to the 5′ end of smGFP sequence and the
PCR products were then cloned into the pGEM-T vector. The synthesized Furin-PG1 gene
sequence was digested by EcoRV and NotI and then inserted into the 3′ end of 6xHissmGFP sequence in the pGEM-T vector. The 6xHis-smGFP-Furin-PG1 sequence was
digested by the NdeI (partial) and NotI enzymes and subcloned into the pLD vector.
Bombardment and selection of transplastomic plants
Sterile tobacco leaves were bombarded using the Bio-rad PDS 1000/He biolistic device as
described previously (Verma et al., 2008). Bombarded leaves were then subjected to three
rounds of selection. First two rounds of selection were performed on the regeneration
medium of plants, and the third round of selection was on Murashige and Skoog medium
without hormone medium. All these were supplemented with 500 mg/L of spectinomycin.
After selection, RC101 and PG1 transplastomic shoots were transferred to pots in the
greenhouse.
PCR analysis to confirm transplastomic plants
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Total plant DNA was isolated from transplastomic tobacco leaves using the DNeasy Plant
Mini Kit from Qiagen (Valencia, CA, USA). PCR was set up with two pairs of primers,
3P-3M and 5P-2M (Verma et al., 2008), to confirm the successful transformation of tobacco
chloroplasts. The 3P primer (AAAACCCGTCCTCAGTTCGGATTGC) anneals with the
native chloroplast genome, and 3M primer (CCGCGTTGTTTCATCAAGCCTTACG)
anneals with the aadA gene. Therefore, this pair of primers was used to check site-specific
integration of selectable marker genes into the chloroplast genome. The 5P primer
(CTGTAGAAGTCACCATTGTTGTGC) anneals with the aadA gene, and 2M primer
(TGACTGCCCACCTGAGAGCGGACA) anneals with the trnA gene, which were used to
check integration of the transgene expression cassette.
Southern blot to confirm homoplasmy
Total plant DNA was digested with ApaI enzyme and then separated on a 0.8% agarose gel.
After electrophoresis, the gel was soaked in 0.25N HCl depurination solution for 15 min and
then rinsed twice in water, 5 min each. After that, the gel was soaked in transfer buffer (0.4
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N NaOH, 1 M NaCl) for 20 min, and then the dry transfer was set up. After transfer, the
membrane was rinsed with 2 × SSC twice for 5 min each. After the membrane was dry, it
was cross-linked using GS GeneLinker UV Chamber at C3 setting. The 0.81-kbp flanking
sequence probe was prepared by digesting pUC-CT vector with BamHI and BglII (Figure
1a). After the probe was labelled with 32P, hybridization of the membrane was performed
using Stratagene QUICK-HYB hybridization solution and protocol (Stratagene, La Jolla,
CA, USA).
Factor Xa and furin cleavage assays
RC101 tobacco transplastomic leaves (100 mg) were ground in liquid nitrogen and
homogenized in 200 μL of plant extraction buffer (0.1 N NaOH, 1 M Tris–HCl, pH 4.5)
using a mechanical mixer. The homogenized plant extract was then centrifuged for 5 min at
16 000 g at 4 °C. The extract (10 μg) was then incubated with 1 μ of Factor Xa protease in
20 mM Tris–HCl (pH 8.0 @ 25 °C) with 100 mM NaCl and 2 mM CaCl2 overnight at 23 °C.
The cleaved products were loaded with uncleaved RC101 protein extracts on the same gel to
investigate cleavage of RC101-GFP fusion protein. Western blot analysis was performed as
described.
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Total protein from the PG1-GFP transplastomic tobacco leaves was extracted the same way
as RC101-GFP described earlier. The extract (10 μg) from PG1-GFP transplastomic tobacco
leaves was incubated with 1 unit of furin in a total reaction volume of 25 μL containing 100
mM Hepes (pH 7.5, 25 °C), 0.5% Triton X-100, 1 mM CaCl2 and 1 mM 2-mercaptoethanol at
25 °C.
Native polyacrylamide gel electrophoresis and densitometric analysis
Total protein from the RC101-GFP and PG1-GFP transplastomic plants was extracted as
described earlier. The TSP concentration was determined by the Bradford assay, and then
different amount of TSP was loaded with native gel loading buffer (60 mM pH 6.8 Tris–HCl,
25% glycerol and 0.01% Bromophenol blue) into the 12% native polyacrylamide gel. After
electrophoresis, the gel was scanned and analysed for the presence of GFP fusion proteins
using AlphaImager® and AlphaEase® FC software (Alpha Innotech, San Leandro, CA,
USA). The IDVs of the GFP standards and samples were recorded and analysed further.
Western blot analysis
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Frozen leaf materials (100 mg) were ground in liquid nitrogen and then resuspended in 200
μL of plant extraction buffer. The supernatant was collected after centrifuging the sample
for 5 min at 14 000 rpm. The plant extract was mixed with 2× sample loading buffer and
then boiled for 5 min before loading. The transformed and untransformed plant extracts and
recombinant GFP standard (Vector Labs, Burlingame, CA, USA) were loaded onto the 12%
SDS-PAGE gel. The proteins in the gel were then transferred to the nitrocellulose membrane
at 100 V for 1 h. After transfer, the membrane was first blocked in PTM (1X PBS, 0.1%
Tween-20, 3% milk) for 2 h at room temperature and then incubated with chick anti-GFP
primary antibody (Chemicon, Billerica, MA, USA) at 1 : 3000 dilution in PTM for 2 h at
room temperature. After the membrane was washed 3 times with PBS-T (1X PBS, 0.1%
Tween-20), 5 min each time, rabbit anti-chick secondary antibody conjugated with HRP was
added at 1 : 3000 dilution in PTM and then incubated for 1 h at room temperature.
Dot blot assay
The Immobilon-P (PVDF) membrane was prewet in methanol for 1–2 min, rinsed twice
with TBS (500 mM NaCl, 20 mM Tris–HCl pH 7.5) and soaked in TBS until use. Protein
extracts from RC101 transplastomic line and standards (0.25–8 ng of RC101 peptides) were
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resuspended in 0.1% acetic acid and then dotted onto an PVDF membrane. Once the last dot
was soaked in, the membrane was placed in fixation buffer (0.05% glutaraldehyde in 1X
TBS) and rocked on the orbital shaker at room temperature for 20 min. The membrane was
blocked for 30 min at 37 °C using Superblock (Pierce, Rockford, IL, USA) and then
incubated overnight with anti-RC101 polyclonal antisera (Invitrogen custom antibody
service, Carlsbad, CA, USA) diluted 1 : 2000 in antibody buffer (Superblock diluted 1 : 3 in
TBS containing 0.05% Tween-20 and 0.01% thimerosal). After washing twice and blocked
again for 15 min, the membrane was incubated with peroxidaseconjugated anti-rabbit
immunoglobulin G for 1 h. After washing, the membrane was developed with Immun-Star
HRP (Bio-Rad, Hercules, CA, USA). Images were captured and analysed using the Bio-Rad
ChemiDoc system.
PG-1 furin cleavage assay and silver staining
After furin digestion, PG1 was cleaved off from GFP. Because of nonavailability of PG1
antibody, we used silver staining to investigate the presence of the 2.1 kDa PG1 protein after
furin cleavage. The cleaved products of PG1-GFP fusion protein were separated in a 16.8%
tris–tricine gel to get the maximum resolution in the ≤10 kDa range. Untransformed plant
extracts, Marker 12 unstained standard (Invitrogen), PG1-GFP plant protein extracts before
and after furin digestion were mixed with sample loading buffer and loaded on the 16.8%
gel. After electrophoresis, the gel was stained by silver staining.
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Confocal microscopy
Untransformed, RC101-GFP and PG1-GFP transplastomic tobacco leaves were harvested
fresh before microscopic analysis. They were cut into 5 × 5 mm small pieces and fixed on
slides. Confocal microscope (Olympus FluoView, Center Valley, PA, USA) with adjustable
bandwidths of the detected fluorescence wavelength was used. The filter used was 505–525
nm. GFP fluorescence from the samples was detected and saved as digital format files.
ELISA quantification of RC101-GFP and PG1-GFP fusion proteins
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All untransformed, transplastomic plant protein extracts (all the extracts used here were the
same as used in Bradford assay) and recombinant GFP standard (Vector Laboratories,
Burlingame, CA, USA, MB-0752) were diluted using the ELISA coating buffer (15 mM
Na2CO3, 35 mM NaHCO3, pH 9.6). The recombinant GFP standard was serially diluted from
100 to 3.125 ng/mL. Different dilutions of test samples were prepared ranging from 1 : 1000
to 1 : 9000. The wells of a 96-well microtiter EIA plate were coated with 100 μL of diluted
test samples and standards. The plate was covered with an adhesive plastic and incubated for
2 h at room temperature. After incubation, the coating solution was removed and the plate
was washed twice by filling the wells with 200 μL PBS and once by water. The coated wells
were blocked by adding 200 μL of blocking buffer (3% dry milk in PBS). Then, the plate
was covered and incubated for 2 h at room temperature. After removing the blocking buffer,
the plate was washed again as described before. Mouse anti-GFP IgG monoclonal antibody
(Chemicon, MAB3836) at 1 : 2000 dilution was added and incubated for 2 h at room
temperature. After washing twice with PBS and once with water, HRP-conjugated goat antimouse IgG antibody (American Qualex, San Clemente, CA, USA) at 1 : 2000 dilution was
added and incubated for 2 h at room temperature. After washing, the plate was developed
with TMB (3, 3′, 5, 5′—Tetramethylbenzidine). The absorbance of each well was read with
a microplate reader (Bio-rad, model 680).
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Purification of RC101-GFP and PG1-GFP fusion proteins by affinity chromatography or
organic extraction
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Fresh leaves (10 g) were ground in liquid nitrogen. Lysis buffer (10 mM Imidazole (pH 8.0),
50 mM Na/K Phosphate buffer, 20 mM Tris–HCl, 300 mM NaCl) (75–80 mL) and one tablet of
pro-tease inhibitor cocktail (Roche-Complete, EDTA-free) were added to the ground leaf
powder. The sonicated sample was centrifuged at 75 000 g for 1 h at 10 °C. The supernatant
was filtered using a Mira cloth to remove debris and loaded onto the column.
The sample lines of the AKTA-3D FPLC were primed and purged before loading the
samples at the rate of 3 mL/min. The fraction size was 2.5 mL. The samples were subjected
to affinity chromatography, and the elution was performed at 100% gradient, which was 250
mM imidazole. The peak at the right wavelength (498 nm) was noted, and all the fractions
comprising that peak were taken. The purified proteins were then separated on the native
PAGE gel. The gel was stained by coomassie staining and viewed directly.
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The organic extraction protocol described by Skosyrev et al. (2003) was used. Saturated
ammonium sulphate (pH 7.8) was added to a final saturation of 70% to the plant protein
extract. The entire suspension was extracted twice with a one-fourth and a 1/16th volume of
ethanol by vigorous shaking for 1 min. After centrifugation, both ethanol phases were
collected carefully to avoid disturbance of the interphase. A one-fourth volume of n-butanol
was added to the combined ethanol extract. After vigorous shaking and centrifugation, the
lower phase containing fusion protein was carefully collected. Lower phase was adjusted to
20% saturation of ammonium sulphate and loaded directly to a column with ButylToyopearl equilibrated with 20% ammonium sulphate in 10 mM Tris–HCl, pH 7.8. After
washing with the equilibration buffer, protein was eluted with salt-free 10 mM Tris–HCl, pH
7.8.
In planta assay for resistance to Erwinia soft rot
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To investigate bacterial resistance of RC101 and PG-1 transplastomic line, untransformed
control and transplastomic leaves were inoculated with bacterial suspension culture. E.
carotovora strain was obtained from Dr. Jerry Bartz's laboratory (University of Florida,
Gainesville) and grown for 24 h at 25 °C in 5 mL of nutrient broth (NB) medium (Difco,
Lawrence, KS, USA). Different dilutions of bacteria were prepared. Five- to 7-mm areas of
greenhouse-grown untransformed, RC101 and PG-1 transplastomic tobacco leaves were
scraped with fine-grain sandpaper, and 20 μL of 108, 106, 104 and 102 of Erwinia cells was
inoculated to each prepared area. In a parallel study, 20 μL of 108, 106, 104 and 102 of
Erwinia cells was injected into leaves of untransformed, RC101 and PG-1 transplastomic
tobacco using a syringe with a precision glide needle. Photographs were taken 5 days after
inoculation.
Erwinia carotovora inoculation and analysis
The leaves of untransformed and transplastomic tobacco plants were inoculated with 20 μL
of bacterial suspension (1.0 × 105 cfu/mL) through a syringe. Each leaf disc (0.8 cm
diameter) was punched off from the inoculated area of an individual plant after 0, 1 or 3
days of incubation. The bacterial population inside the leaf was calculated as follows. Leaf
tissue was ground in 100 μL sterilized water in a microcentrifuge tube. The suspension was
serially diluted with sterilized water and was then plated on nutrient broth agar plates
(Difco). Colonies were counted after 1 day of incubation at 25 °C.
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Tobacco Mosaic Virus (TMV) inoculation and analysis
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Full-length infectious TMV RNA transcripts were generated by in vitro transcription of
KpnI-linearized Klenow-filled pTMV004 vector (Obtained from Prof. William Dawson,
University of Florida Citrus Research and Education Center, Lake Alfred) using T7 RNA
polymerase (Promega, Madison, WI, USA), as described before (Dinesh-Kumar and Baker,
2000). In vitro-generated TMV transcripts were rub-inoculated onto tobacco plants, and
infected leaves were harvested 14 days after inoculation and re-inoculated onto tobacco
plants for virus multiplication. The inoculum for plant infection was prepared by grinding
infected TMV-sensitive tobacco leaf tissues in 10 mM sodium phosphate buffer, pH 7.0. The
leaf sap with virus was then injected into the main veins of 4 to 5-week-old PG1, RC101
transplastomic and untransformed tobacco plant leaves using a syringe. Plants were
evaluated for the development of symptoms to TMV infection for 20 days after inoculation.
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Figure 1.
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Schematic representation of chloroplast vectors. (a) The native chloroplast genome showing
both homologous recombination sites (trnI and trnA) and the restriction enzyme sites used
for Southern blot analysis. (b) The pLD-His6-GFP-Furin-PG1 vector map with the primer
annealing sites. (c) The pLD-GFP-His6-Factor Xa-retrocyclin-101 (RC101) vector map;
primer annealing sites are the same as shown on the PG1 vector map. (d) The nucleotide
sequence of GFP-6xHis-Factor Xa-RC101 and the schematic representation of disulphide
bonds in RC101. (e) The nucleotide sequence of 6xHis-GFP-Furin-PG1 and the schematic
representation of disulphide bonds in PG1.
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Figure 2.

PCR and Southern blot analysis to investigate transgene integration and homoplasmy. (a)
PCR analysis of the untransformed and transplastomic lines using the primer pair 3P/3M.
Lanes 1–3: retrocyclin-101 (RC101) transplastomic lines; 4–6: PG1 transplastomic lines. (b)
PCR analysis of the untransformed and transplastomic lines using the primer pair 5P/2M.
Lanes 1–3: RC101 transplastomic lines; 4–6: PG1 transplastomic lines. (c) Southern blot
hybridized with the flanking sequence trnI-trnA probe to investigate the homoplasmy of
RC101 and PG1 transplastomic lines. Lanes 1–2, DNA samples from RC101 transplastomic
plants; lanes 3–4, PG1 transplastomic plants. M, 1-kbp DNA plus ladder; WT,
untransformed tobacco.
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Figure 3.
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Protease cleavage of the fusion proteins by immunoblot and quantification of expression by
densitometric analysis. (a) Immunoblot analysis of retrocyclin-101 (RC101)-GFP and PG1GFP expression and cleavage. 1: untransformed protein extract, 10 μg; 2: precision plus
protein marker, 5 μg; 3: RC101-GFP transplastomic line protein extract, 3 μg; 4: RC101GFP protein extract digested by Factor Xa protease, 3 μg; 5: PG1-GFP protein extract, 6 μg;
6: PG1-GFP protein extract digested by furin protease, 6 μg; 7: GFP standard, 100 ng. (b)
Native polyacrylamide gel electrophoresis of RC101-GFP and PG1-GFP protein extracts.
Lanes 1–3, GFP standard (150, 300, 600 ng); lane 4, untransformed plant extract, 10 μg;
lanes 5–6, RC101 transplastomic extracts (6, 8 μg); lanes 7–8, PG1 transplastomic extracts
(6, 8 μg). (c) GFP standard curve based on the integrated density values of 150, 300 and 600
ng of GFP standard. (d) Estimation of RC101-GFP and PG1-GFP expression levels in
transplastomic plants.
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Figure 4.

Dot blot analysis and silver staining to investigate expression of retrocyclin-101 (RC101)
and PG1. (a) Dot blot analysis of RC101 before and after cleavage. Indicated amount of
RC101 was used as standards. Uncut, RC101-GFP without Factor Xa cleavage; Cut, RC101GFP after Factor Xa cleavage. (b) Silver-stained gel of plant extracts before or after furin
cleavage of PG1-GFP protein. 1: Marker 12 (invitrogen); 2: Untransformed plant protein
extract, 40 μg; 3: PG1-GFP protein extract without furin digestion, 40 μg; 4: PG1-GFP
protein extract digested by furin protease, 40 μg.
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Figure 5.

Confocal microscopy of retrocyclin-101 (RC101)-GFP and PG1-GFP transplastomic plants.
The left panels show chloroplasts from RC101-GFP (a) or PG1-GFP (b) transplastomic lines
(bars = 20 μm). The right panels show four times higher magnification of the boxed regions
(bars = 5 μm).
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Figure 6.

Purified retrocyclin-101 (RC101)-GFP and PG1-GFP fusion proteins were separated on
native PAGE and observed by Coomassie staining or fluorescence under UV light. PG1GFP was purified by affinity chromatography, and RC101-GFP was purified by both affinity
chromatography and organic extraction method. Samples were loaded in duplicate. M,
Precision Plus protein marker, 5 μg; St, GFP standard, 500 ng. The same gel was observed
under UV light (bottom) or stained by Coomassie staining (top). The yield of RC101-GFP
was 5 μg/g leaf by affinity chromatography and 53 μg/g leaf by organic extraction; PG1GFP yield was 8 μg/g leaf by affinity chromatography purification.
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Figure 7.

In planta antimicrobial bioassays to investigate functionality of retrocyclin-101 (RC101) and
PG1 expressed in chloroplasts. Twenty microliter of the 108, 106, 104 and 102 cells from an
overnight culture of Erwinia carotovora was injected into leaves of (a) RC101, (e) PG-1
transplastomic and (b, f) untransformed (UT) plants using a syringe with a precision glide
needle. Five- to 7-mm areas of (c) RC101, (g) PG-1 and (d, h) untransformed leaves were
scraped with fine-grain sandpaper. Twenty microliter of the 108, 106, 104 and 102 cells of
Erwinia was inoculated to each prepared area. Photographs were taken 5 days after
inoculation.
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Figure 8.

Bacterial density in the PG1, retrocyclin-101 (RC101) and untransformed (UT) plants
inoculated with Erwinia carotovora. (a) Bacterial density in RC101 and untransformed
leaves. (b) Bacterial density in PG1 and untransformed leaves. The bacterial density in
plants on 0, 1 and 3 days after inoculation. All values represent means of six replications
with standard deviations shown as error bars.
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Figure 9.

Response of untransformed and retrocyclin-101 (RC101)/PG1 transplastomic plants to
tobacco mosaic virus (TMV). (a) TMV-inoculated leaf from untransformed plant; (b) TMVinoculated leaf from transplastomic PG1 plant. (c) TMV-inoculated leaf from transplastomic
RC101 plant. Pictures were taken on 20 days after inoculation.
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